期刊文献+

circGLS2 inhibits hepatocellular carcinoma recurrence via regulating hsa-miR-222-3p–PTEN–AKT signaling

原文传递
导出
摘要 Dear Editor,Growing evidences indicate that circRNAs affect hepatocellular carcinoma(HCC)progression.1,2,3,4 Understanding the roles of circRNAs in HCC recurrence helps develop innovated therapies.To identify novel HCC recurrence-related circRNA,thirteen HCC patients were subjected to a multi-omics analysis of mRNA,circRNA.
出处 《Signal Transduction and Targeted Therapy》 SCIE CSCD 2023年第3期901-904,共4页 信号转导与靶向治疗(英文)
基金 This work was funded by National Natural Science Foundation of China(81520108021,91529305,81673250,and 81521091 to GC,and 81373067 to JY) Program of Shanghai Academic Research Leader(22XD1404800 to JY) the National Key Basic Research Program(973 program)(2015CB554000 to GC,and 2015CB554005 to JY).We acknowledge Dr.Mei Liu and Dr.Donghong Liu who took part in key experiments concerning ChIP-qPCR,subcellular localization of circGLS2 and western blot assays during revising this study.
关键词 GLS CARCINOMA AKT
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部